Creating Access to Health Technologies in Poor Countries

2015 ◽  
Author(s):  
Laura J. Frost ◽  
Michael R. Reich
Keyword(s):  
Poor Countries ◽  
Health Technologies ◽  
Access To Health

Creating Access To Health Technologies In Poor Countries

2009 ◽  
Vol 28 (4) ◽  
pp. 962-973 ◽  
Author(s):  
Laura J. Frost ◽  
Michael R. Reich
Keyword(s):  
Poor Countries ◽  
Health Technologies ◽  
Access To Health

Patents, Access to Health Technologies, and Christianity

2021 ◽  
pp. 182-212
Author(s):  
Margo A. Bagley ◽  
Danielle C. Lloyd
Keyword(s):  
Health Technologies ◽  
Access To Health

Novel partnerships help poor countries extend access to health services

BMJ ◽  
2010 ◽  
Vol 340 (jun01 2) ◽  
pp. c2897-c2897
Author(s):  
T. Richards
Keyword(s):  
Health Services ◽  
Access To Health Services ◽  
Poor Countries ◽  
Access To Health

scholarly journals COVID-19 and the global public health: Tiered pricing of pharmaceutical drugs as a price-reducing policy tool

2020 ◽  
pp. 174113432096314
Author(s):  
Muhammad Zaheer Abbas
Keyword(s):  
Policy Option ◽  
Practical Significance ◽  
Pharmaceutical Drugs ◽  
Global Public Health ◽  
Health Technologies ◽  
Policy Tool ◽  
Tiered Pricing ◽  
Or Groups ◽  
Access To Health ◽  
Financial Burdens

The current COVID-19 pandemic has put the problem of equitable access to health technologies in the limelight because governments, even in the economically advanced countries, are struggling to meet the health needs of their populations. Tiered pricing of innovative health technologies, which involves the division of markets into different tiers or groups, provides a legitimate policy tool to alleviate some of the COVID-19 financial burdens on global health systems. Differential pricing denotes the practice of companies to charge different prices for the same product depending on the different classes of purchasers. This paper examines the legality and practical significance of tiered pricing as a price-reducing policy option and discusses some of the key limitations of this important policy tool. This study proposes the adoption of a global framework for sustainable pricing and tiered pricing of innovative health technologies. The proposed global framework will help in achieving a balance between fair access and fair profit levels.

PP155 The Impact Of Lawsuits In The Brazilian Public Health System

2017 ◽  
Vol 33 (S1) ◽  
pp. 141-141
Author(s):  
Carla Biella ◽  
Viviane Pereira ◽  
Fabiana Raynal ◽  
Jorge Barreto ◽  
Vania Canuto ◽  
...  
Keyword(s):  
Public Health ◽  
Health Care ◽  
Health System ◽  
Public Health System ◽  
Scientific Evidence ◽  
Health Technology ◽  
Health Technologies ◽  
Access To Health ◽  
The Right ◽  
The Impact

INTRODUCTION:The increase of litigation in Brazil on the right to health, and the Brazilian Public Health System (SUS) targets of litigation, are phenomena that generate discussions both in the judiciary, and among researchers and managers of health. The lawsuits are based on the integrality that includes the right to any health technology. Our aim was to gather information on the use of scientific evidence by judges and other law professionals to support their decisions in lawsuits involving health care in Brazil.METHODS:A narrative review by literature search using key terms of legalization in specific databases was conducted.RESULTS:Twenty-five studies showed litigation matters relating to health care which were focused on legal claims about drugs. In general, law operators used the scientific evidences in a limited way when making decisions, by considering the medical report and medication label indications and disregarding therapeutic alternatives contemplated in the SUS list. The access to health technologies, by litigation, reveals that the gap between scientific knowledge and legal practice are similar to those found between science and decision-making in the formulation and implementation of health policies. The Health Technology Assessment studies have high potential for use by the judiciary as a reference source to support technical and scientific decisions in lawsuits on health care.CONCLUSIONS:For the judiciary to ensure not only access to health technologies, but also the efficacy and safety of technologies to system users, their decisions must be substantiated by scientific evidence. The National Committee for Health Technology Incorporation (CONITEC) in SUS has established actions in conjunction with law operators and society, such as a communication using e-mail, aiding the decision for the injunction and elaboration of technical reports and a policy brief, with the intention that the decisions are taken with the greatest possible knowledge about technologies provided by SUS, and based on scientific evidence.

Prizes and Parasites: Incentive Models for Addressing Chagas Disease

2009 ◽  
Vol 37 (2) ◽  
pp. 292-304 ◽  
Author(s):  
Sara E. Crager ◽  
Matt Price
Keyword(s):  
Infectious Diseases ◽  
Neglected Diseases ◽  
Colonial Era ◽  
Post Colonial ◽  
Poor Countries ◽  
Health Technologies ◽  
Disease Research ◽  
Market Sector ◽  
New Chemical Entities ◽  
Made In

Despite the enormous progress made in the advancement of health technologies over the last century, infectious diseases continue to cause significant morbidity and mortality in developing countries. Neglected diseases are a subset of infectious diseases that lack treatments that are effective, simple to use, or affordable. Neglected diseases primarily affect populations in poor countries that do not constitute a lucrative market sector, thus failing to provide incentives for the pharmaceutical industry to conduct R&D for these diseases. Of the treatments that do exist for neglected diseases, most are completely out-dated, with poor side-effect profiles, cumbersome logistics of administration, and inadequate efficacy. Historically, the impetus for a majority of neglected disease research was driven by early 20th-century colonialism, and in the post-colonial era, these diseases have been virtually ignored. Of the 1556 New Chemical Entities (NCEs) brought to market during the 30-year period from 1975 to 2004, only 20 — less than 0.02% — were for neglected diseases.

Skilled Human Resources in the Health Sectors and Impacts of New Health Technologies on Health Workforce in Developing Economies

2013 ◽  
pp. 23-50
Author(s):  
Ahmed Driouchi
Keyword(s):  
Human Resources ◽  
Access To Health Care ◽  
Developing Economies ◽  
Health Resources ◽  
Developed Countries ◽  
Negative Effects ◽  
Health Technologies ◽  
Access To Health ◽  
Development Processes ◽  
New Instruments

This chapter focuses on the importance of human health resources in relation to current and future trends in health. It is based on a syntheses of reports, publications, and economic development processes related to the increasing needs for skilled human resources in health systems that are under both high demand and also under the requirements of new health technologies. A special emphasis is placed on developing countries where a series of constraints could lead to limits in providing access to health care and a shortage of skilled labor. The human resources related risks at both levels of developed and developing economies are also discussed even though emergent and developed countries have generated new instruments to limit the negative effects of these constraints. Finally, if the expansion of access to new health technologies could be achieved within the world global health system framework, requirements of increasingly needed human resources and skills are shown.

Sign in / Sign up

Export Citation Format

Share Document